Status:

COMPLETED

Management of the Patient at High Risk Hemorrhagic in Cardiac Surgery by Monitoring Viscoelastic Hemostasis.

Lead Sponsor:

University Hospital, Brest

Conditions:

Cardiac Surgery

Eligibility:

All Genders

18+ years

Brief Summary

Evaluation and following of a protocol using viscoelastic test for the management of high risk patients in cardiac surgery

Detailed Description

Haemorragy is a frequent issue in cardiac surgery due to multiple contributing factors. Excessive bleeding as well as transfusion are associated with increased morbidity and mortality. Haemostatic bl...

Eligibility Criteria

Inclusion

  • Inclusion Criteria :
  • Adult patients
  • Elective or non-elective high risk of bleeding heart surgery
  • Non-opposition
  • Exclusion Criteria:
  • Pregnant women
  • Age \< 18 years
  • Patients under guardianship
  • Opposition

Exclusion

    Key Trial Info

    Start Date :

    March 20 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 23 2022

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT06550505

    Start Date

    March 20 2020

    End Date

    March 23 2022

    Last Update

    August 13 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    CHRU BREST, Hôpital de la Cavale Blanche

    Brest, France, 29200

    Management of the Patient at High Risk Hemorrhagic in Cardiac Surgery by Monitoring Viscoelastic Hemostasis. | DecenTrialz